CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Long Covid: Could This Be Why?

MICROCLOTS. COULD THEY EXPLAIN the mystery of why some who get a COVID19 infection suffer for long periods? Three hundred three million cases worldwide and...

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

Perrigo Voluntarily Recalls Albuterol Sulfate Inhalation Aerosol

A voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol to the retail level after previously halting production and distribution.